SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-22-015938
Filing Date
2022-06-27
Accepted
2022-06-27 08:44:04
Documents
2
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 8624
2 jacobpoa.txt EX-24 3589
  Complete submission text file 0001437749-22-015938.txt   13797
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address
Jacob Jeffrey E. (Reporting) CIK: 0001934189 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39468 | Film No.: 221041659